Search Results for: Rexahn Pharmaceuticals Announces Collaboration Wit
Articles
February 13, 2018
Rexahn Pharmaceuticals Announces Collaboration With Zhejiang Haichang Biotechnology February 13, 2018
Rexahn Pharmaceuticals, Inc. recently announced it has entered into a collaboration and license agreement with Zhejiang Haichang Biotechnology Co., Ltd....
August 24, 2018
Rexahn Pharmaceuticals Announces Clinical Collaboration With Merck August 24, 2018
Rexahn Pharmaceuticals, Inc. recently announced it has entered into a clinical trial collaboration agreement with Merck (known as MSD outside the United States and Canada) to evaluate the combination of Rexahn’s RX-5902 and Merck’s anti-PD-1 therapy, KEYTRUDA (pembrolizumab) in a Phase 2 trial in patients with metastatic triple negative breast cancer (TNBC).
